Endocrine Abstracts

Previous issue | Volume 13 | SFEBES2007 | Next issue

Society for Endocrinology BES

Plenary Lecturers’ Biographical Notes
- Society for Endocrinology Dale Medal Lecture
- - The ever expanding role of somatostatin receptors in endocrine disease
    
    ea0013s1
  - Society for Endocrinology Dale Medal Lecture
    
    ea0013s1biog
- Society for Endocrinology Transatlantic Medal Lecture
- - PGC-1 coactivators and the control of energy homeostasis
    
    ea0013s2
  - Society for Endocrinology Transatlantic Medal Lecture
    
    ea0013s2biog
- Society for Endocrinology Asia and Oceania Medal Lecture
- - From Ad4BP/SF-1 to cell and tissue differentiation
    
    ea0013s3
  - Society for Endocrinology Asia and Oceania Medal Lecture
    
    ea0013s3biog
- Society for Endocrinology European Medal Lecture
- - GH/IGF-I and the cardiovascular system
    
    ea0013s4
  - Society for Endocrinology European Medal Lecture
    
    ea0013s4biog
- The British Thyroid Association Pitt Rivers Lecture
- - Genes that mediate thyroid hormone functions in development
    
    ea0013s5
  - The British Thyroid Association Pitt Rivers Lecture
    
    ea0013s5biog
- Clinical Endocrinology Trust Visiting Professor Lecture
- - Genes and environment in the pathogenesis of polycystic ovary syndrome (PCOS)
    
    ea0013s6
  - Clinical Endocrinology Trust Visiting Professor Lecture
    
    ea0013s6biog
- Society for Endocrinology Medal Lecture
- - Cortisol and cardiovascular disease: from cradle to grave
    
    ea0013s7
  - Society for Endocrinology Medal Lecture
    
    ea0013s7biog
- Clinical Endocrinology Trust Lecture
- - Failing to stop, failing to signal, no insurance, and other trafficking defects in the adrenal
    
    ea0013s8
  - Clinical Endocrinology Trust Lecture
    
    ea0013s8biog
Symposia
- Transdifferentiation in the endocrine system
- - Fibroblasts and tissue remodelling: Defining a role for fibroblasts in the persistence of chronic inflammation
    
    ea0013s9
  - Transdifferentiation in the osteoblast
    
    ea0013s10
  - Plasticity of the adipose organ
    
    ea0013s11
  - Pancreatic trans-differentiation and the treatment of liver damage
    
    ea0013s12
- Thyroid and autoimmunity
- - Pathogenic and regulatory T cells in a humanised model of hypothyroidism
    
    ea0013s13
  - Novel animal models of Graves’ hyperthyroidism
    
    ea0013s14
  - The TSH receptor: from natural variants to structure and function
    
    ea0013s15
  - TSH receptor antibodies – should we measure them and if so how?
    
    ea0013s16
- Endocrinology of senescence
- - The role of androgens in the ageing male
    
    ea0013s17
  - Estrogen receptors in development and ageing
    
    ea0013s18
  - Functional decline in mobility muscles and somatopause
    
    ea0013s19
  - Stress hormones, innate immunity and ageing
    
    ea0013s20
- Endocrine stem cells
- - Precursors to pancreatic beta cells
    
    ea0013s21
  - Replacing beta cells: proof-of-principle and the stem cell option
    
    ea0013s22
  - Nuclear transfer and stem cell-based therapies: tailored treatment
    
    ea0013s23
  - Conditional ablation and regeneration of pancreatic beta cells
    
    ea0013s24
- Novel endocrine consequences of stress
- - New roles for the CRF-R2
    
    ea0013s25
  - Exercise alters endocrine and behavioural consequences of stress
    
    ea0013s26
  - Corticotropin Releasing Hormone (CRH) system and inflammation
    
    ea0013s27
  - Urocortins and peripheral energy metabolism
    
    ea0013s28
- Vitamin D – new perspectives
- - The Vitamin D receptor as a dual-functional mediator of endocrine and detoxification pathways
    
    ea0013s29
  - The epithelial calcium channels: uniquely regulated gatekeepers
    
    ea0013s30
  - Vitamin D and cancer prevention
    
    ea0013s31
  - Vitamin D and autoimmune disease
    
    ea0013s32
- Animal disease, paradigm for human conditions
- - Hyperadrenocorticism – current treatment options
    
    ea0013s33
  - Stress and sex on the farm – lessons for humans
    
    ea0013s34
  - Canine diabetes mellitus
    
    ea0013s35
  - Feline hyperthyroidism: parallels with human hyperthyroidism
    
    ea0013s36
- Aspects of cardiovascular risk management in diabetes
- - The value of PPAR agonists in relation to endothelial function
    
    ea0013s37
  - Developments in the dyslipidaemia of diabetes
    
    ea0013s38
  - Cardiovascular risk and risk management in type 1 diabetes
    
    ea0013s39
  - Aldosterone induced vascular inflammatory disease: Mechanisms and implications for clinical practice
    
    ea0013s40
- New biology of bone: therapeutic implications
- - LRP5
    
    ea0013s41
  - Osteoclast differentiation and function
    
    ea0013s42
  - Rank modulation in treatment
    
    ea0013s43
  - Cathespins and bone and other new targets
    
    ea0013s44
Clinical Management Workshops
- Management of endocrine disorders in pregnancy: the mother and the child
- - Hyperglycaemia in pregnancy
    
    ea0013s45
  - CAH – pregnancy and antenatal glucocorticoid treatment
    
    ea0013s46
  - Thyroid disease in pregnancy
    
    ea0013s47
  - Maternal vitamin D status in pregnancy and risk to the child
    
    ea0013s48
  - The use of insulin sensitisers in the adolescent
    
    ea0013s49
  - The role of weight reduction strategies in the management of PCOS
    
    ea0013s50
  - Practical aspects of managing subfertility in polycystic ovary syndrome
    
    ea0013s51
  - Management of the cosmetic aspects of PCOS
    
    ea0013s52
- New aspects of phaeochromocytoma
- - Familial phaeochromocytoma syndromes
    
    ea0013s53
  - New aspects of phaeochromocytoma: Managing young people with phaeochromocytoma
    
    ea0013s54
  - Biochemical testing – which test in which patient
    
    ea0013s55
  - Clinical case discussion
    
    ea0013s56
- Differentiated thyroid cancer
- - Clinical management of thyroid cancer: new guidelines
    
    ea0013s57
  - Surgical management of differentiated thyroid cancer (DTC)
    
    ea0013s58
  - An update in the management practices of thyroid cancer and the use of rhTSH
    
    ea0013s59
Nurse Session
- Thyroid cancer – more than a lump in the neck
- - Helping the patient through different types of thyroid cancer
    
    ea0013s60
  - Controlling calcium following thyroidectomy
    
    ea0013s61
  - Patient groups and the nurses involvement
    
    ea0013s62
  - The thyroid cancer patient journey and the role of the clinical nurse specialist
    
    ea0013s63
- Dealing with MEN
- - Dealing with MEN: an overview
    
    ea0013s64
  - Genetic counsellor contribution to the MEN patient
    
    ea0013s65
  - Dealing with MEN: A paediatric perspective
    
    ea0013s66
  - Adult case
    
    ea0013s67
Young Endocrinologists Session
- A successful research career
- - MD VS PhD
    
    ea0013s68
  - Managing your PhD
    
    ea0013s69
  - Fraud and plagiarism
    
    ea0013s70
  - Making money out of research
    
    ea0013s71
Molecular Endocrinology Workshop
- Nuclear hormone receptor-chromatin interactions: new approaches and insight into dynamics
- - Chip-chip approaches to understanding ER function
    
    ea0013s72
  - Dynamics of nuclear receptor interactions on chromatin
    
    ea0013s73
Clinical and Basic Review Lectures
- Applications of proteomics in translational research
- - Proteomics in research and clinic
    
    ea0013s74
- Pharmacological aspects of appetite control
- - The obesity pipeline: current strategies in the development of anti-obesity drugs
    
    ea0013s75
Education Technology Session
- Science
- - Role of micro RNAs in development and disease
    
    ea0013s76
Clinical Debate
- This house believes that all patients with sub-clinical thyrotoxicosis should be treated
- - This house believes that all patients with subclinical thyrotoxicosis should be treated: For the motion
    
    ea0013d1
  - This house believes that all patients with subclinical thyrotoxicosis should be treated: Against the motion
    
    ea0013d2
Oral Communications
- Steroid synthesis and action
- - Monogenic polycystic ovary syndrome (PCOS) due to novel mutations in the H6PD gene - apparent cortisone reductase deficiency (ACRD)
    
    ea0013oc1
  - Mouse melanocortin-2 receptor accessory protein: expression pattern and protein characterisation
    
    ea0013oc2
  - Transcriptional regulation of 11beta-hydroxysteroid dehydrogenase type 1 under the synergistic control of glucocorticoids and cytokines
    
    ea0013oc3
  - Modulation of membrane initiated glucocorticoid signalling by caveolin-1
    
    ea0013oc4
- Society for Endocrinology/Clinical Endocrinology Trust Young Investigator Basic Prize winner
- - Hexose-6-phosphate dehydrogenase: A novel regulator of glucocorticoid hormone action
    
    ea0013oc5
  - A novel tethering mechanism explains cell type specific glucocorticoid repression of macrophage migration inhibitory factor (MIF)
    
    ea0013oc6
  - Differential effects of P450 oxidoreductase mutants on CYP17 activity provides evidence for an alternative pathway in human androgen biosynthesis
    
    ea0013oc7
- Clinical and translational endocrinology
- - Effect of once-yearly infusion of Zoledronic acid 5 mg in postmenopausal women with osteoporosis
    
    ea0013oc8
  - A novel homozygous inactivating mutation, Pro339Thr, of the calcium-sensing receptor is associated with isolated primary hyperparathyroidism
    
    ea0013oc9
  - Expression of the orphan nuclear receptors oestrogen receptor related (ERR) alpha and beta in the human endometrium: implications for oestrogen receptor signalling
    
    ea0013oc10
  - Reduced 5α-reductase activity in peripheral blood mononuclear cells in polycystic ovarian syndrome – a compensatory mechanism for androgen excess?
    
    ea0013oc11
  - Local and systemic consequences of glucocorticoid metabolism in synovium
    
    ea0013oc12
  - Relative protection of cortical bone in women with complete androgen insensitivity syndrome compared to women with gonadal dysgenesis
    
    ea0013oc13
  - A two-centre experience of long-term pegvisomant therapy in 58 patients
    
    ea0013oc14
  - Biological variability of insulin resistance in polycystic ovarian syndrome after treatment with Metformin, Orlistat and Pioglitazone
    
    ea0013oc15
- Young Endocrinologist prize session
- - Heterozygous missense mutations in steroidogenic factor 1 (SF1/Ad4BP, NR5A1) cause 46,XY disorders of sex development with normal adrenal function
    
    ea0013oc16
- Novartis Clinical Endocrinology Award
- - Kisspeptin-54 potently stimulates luteinising hormone release during the preovulatory phase of the menstrual cycle in healthy human females.
    
    ea0013oc17
  - Sedlin mutations disrupt interactions with pituitary homeobox 1 (Pitx1) and steroidogenic factor 1 (SF1): potential cause of delayed puberty in boys with Spondyloepiphyseal dysplasia tarda (SEDT)
    
    ea0013oc18
- Novartis Basic Endocrinology Award
- - Steroidogenic gene transcription in the human hippocampus and cerebellum: a comprehensive survey
    
    ea0013oc19
  - Insulin fails to limit proteolysis in critically-ill medical patients to rates observed after cardiothoracic surgery
    
    ea0013oc20
  - Muscle cell differentiation is regulated by glucocorticoids, a process which is potentiated through the induction of 11 beta-hydroxysteroid dehydrogenase type 1 (11β-HSD1)
    
    ea0013oc21
  - Mice deleted for a Multiple Endocrine Neoplasia Type 1 (MEN1) allele develop pancreatic, pituitary and parathyroid tumours in association with hypercalcaemia
    
    ea0013oc22
  - The corticotropin-releasing factor type 2 receptor selective ligand Urocortin 3 suppresses angiogenesis in vitro and in vivo
    
    ea0013oc23
- Neuroendocrinology, reproduction and cardiovascular
- - Acute aldosterone responses to ACTH predict both cortisol responses and blood pressure
    
    ea0013oc24
  - Manipulation of proprotein convertase 1 expression in AtT20 cells changes proopiomelanocortin processing and trafficking: Implications for ACTH regulatory pathways
    
    ea0013oc25
  - Molecular mechanism of action of annexin A1 in controlling hormone release from neuroendocrine cells
    
    ea0013oc26
  - Manganese-enhanced MRI demonstrates that oxyntomodulin and GLP-1 affect neuronal activity in distinct regions of the brain
    
    ea0013oc27
  - The effect of glucocorticoid withdrawal after long-term treatment on POMC and its transcription factors
    
    ea0013oc28
  - Effects of insulin-like growth factor 1 (IGF-1) on early folliculogenesis in polycystic ovaries from ovulatory and anovulatory women
    
    ea0013oc29
  - Consequences of variation in the CYP11B2 and CYP11B1 genes on hypothalamic-pituitary-adrenal axis activity
    
    ea0013oc30
- 2005 Pfizer Award
- - Evidence for associations between fibroblast growth factor 1 gene and human hypertension
    
    ea0013oc31
- Society for Endocrinology/Clinical Endocrinology Trust Young Investigator Clinical Prize winner
- - Extreme insulin resistance syndromes – beyond glucose homeostasis
    
    ea0013oc32
  - Tag SNP screening of the PDCD1 gene for association with Graves’ disease
    
    ea0013oc33
- British Thyroid Association Award
- - Monocarboxylate transporter 8 (MCT8) represses proliferation of fetal embryonal NT2 and placental JEG-3 cells in vitro
    
    ea0013oc34
  - A prothrombotic clot structure in hyperthyroidism: A mechanism for increased thrombosis in hyperthyroid individuals?
    
    ea0013oc35
  - Comparsion of the NFκB and JNK mediated inflammatory mechanisms for production of adipocytokines in paired human epicardial and gluteo-femoral adipose tissue from CABG patients
    
    ea0013oc36
  - Testosterone replacement attenuates fatty streak formation and improves the HDLC profile in the Tfm mouse: an effect which is independent of the classical androgen receptor
    
    ea0013oc37
  - The novel thyroid hormone derivative 3-iodothyronamine increases food intake via the hypothalamic arcuate nucleus
    
    ea0013oc38
Poster Presentations
- Bone
- - Characterisation of 25 calcium-sensing receptor mutations in disorders of calcium homeostasis
    
    ea0013p1
  - Mechanisms of DNA binding by the transcription factor GATA3 revealed by mutations causing the hypoparathyroidism-deafness-renal dysplasia (HDR) syndrome
    
    ea0013p2
  - Differences in parathyroid hormone secretory rhythm and sensitivity in aging women with osteoporosis and declining insulin like growth factor-1 concentration, compared to young healthy premenopausal women
    
    ea0013p3
  - Mapping of a renal calcification locus to a 5-megabase region on mouse chromosome 17B1/B2
    
    ea0013p4
  - ⁶⁸Ga-DOTANOC based PET-CT co-registration: A novel approach for a rapid and precise tumor localization in oncogenic osteomalacia
    
    ea0013p5
  - Endocrine effects of depot medroxyprogesterone acetate in young women
    
    ea0013p6
  - Can cinacalcet predispose patients to developing postoperative hypocalcaemia following parathyroidectomy for secondary hyperparathyroidism?
    
    ea0013p7
  - Case of parathyroid carcinoma with severe hungry bone syndrome
    
    ea0013p8
  - Diurnal variation in total and bioavailable oestradiol in aging men with osteoporosis
    
    ea0013p9
  - Calcium homeostasis and parathyroid function in Gata3 knockout mice: relevance to the human hypoparathyroidism, deafness and renal dysplasia syndrome
    
    ea0013p10
  - Alendronate accelerates increases in bone mineral density with growth hormone replacement but may attenuate the anabolic effect of growth gormone replacement on bone in adult growth hormone deficiency
    
    ea0013p11
  - Localisation of a renal calcification locus to a 5 Mbp-region on mouse chromosome 11D-E2
    
    ea0013p12
  - Expression and functional consequences of 11b-HSD1 and H6PDH activity in mouse bone cells
    
    ea0013p13
  - Fractures following orthotopic liver transplantation
    
    ea0013p14
  - Hypercalcaemia from vitamin D supplements and parathyroid autonomy: the hazards of DIY therapeutics
    
    ea0013p15
  - Wnt/β-catenin signalling is abrogated in mice with a targeted mutation in the thyroid hormone receptor (TR) β gene and a thyrotoxic skeletal phenotype
    
    ea0013p16
- Clinical practice/governance and case reports
- - Isolated ACTH deficiency in a case of Thyrotoxicosis. Spontaneous cure of ACTH deficiency occurred following radioactive treatment of thyrotoxicosis and its resolution.
    
    ea0013p17
  - Isolated ACTH deficiency presenting twenty two years after radiotherapy for nasopharyngeal carcinoma
    
    ea0013p18
  - Spontaneous recurrent hypoglycaemia due to metastatic gatrointestinal stromal tumour (GIST)
    
    ea0013p19
  - Hypokalemia and paralysis- 2 case reports
    
    ea0013p20
  - Hypercalcemia of benignancy
    
    ea0013p21
  - The steroid mask
    
    ea0013p22
  - An rare cause of reversible left bundle branch block
    
    ea0013p23
  - A case of reversible right-sided heart failure due to Grave’s disease
    
    ea0013p24
  - Unilateral blindness following transphenoidal hypophysectomy for large non-functioning pituitary adenoma
    
    ea0013p25
  - Chorea - A rare manifestation of hyperthyroidism
    
    ea0013p26
  - Familial hypoparathyroidism- case notes review and relevance to clinical practice
    
    ea0013p27
  - Pseudohypoparathyroidism type 1B complicated by parathyroid bone disease and clubbing
    
    ea0013p28
  - Hyperkalemia in a district general hospital
    
    ea0013p29
  - Two cases of “idiopathic” hypopituitarism – Was more intensive investigation required?
    
    ea0013p30
  - The assessment of growth hormone deficiency following pituitary surgery – a need for greater awareness
    
    ea0013p31
  - Spontaneous pregnancy in a woman with premature ovarian failure-a case report
    
    ea0013p32
  - An overnight water deprivation test?
    
    ea0013p33
  - Co-existence of elevated PTH and PTHrP
    
    ea0013p34
  - Pregnancy, hyperaldosteronism and an adrenal mass – were we Conned?
    
    ea0013p35
  - Cabergoline treatment resulting in rapid changes to a prolactinoma
    
    ea0013p36
  - Shrinking adrenal mass: Case report of an adrenal pseudocyst
    
    ea0013p37
  - A case of recurrent hypoglycemia in a patient with type 1 diabetes: when the obvious is not so obvious!
    
    ea0013p38
  - Cinecalcit in the treatment of resistant hypercalcaemia of parathyroid cancer
    
    ea0013p39
  - Case report: Severe hypoglycaemia associated with uterine fibroid
    
    ea0013p40
  - Can parathyroid hormone (PTH) levels be useful in predicting postoperative hypocalcaemia in patients undergoing parathyroidectomy?
    
    ea0013p41
  - Turner syndrome and apparent absent uterus: a case report and review of literature
    
    ea0013p42
  - Severe hyponatraemia – how low can you go?
    
    ea0013p43
  - Should primary care have direct access to thyroid ultrasound?
    
    ea0013p44
  - Di-George syndrome presenting as hypocalcaemia in adulthood
    
    ea0013p45
  - Drug-induced symptomatic hypomagnesaemia and hypocalcaemia
    
    ea0013p46
  - Audit of testosterone replacement therapy at South Tyneside
    
    ea0013p47
  - Restoration of gonadal function and development in hypogonadotrophic hypogonadism
    
    ea0013p48
  - Severe cushing’s syndrome associated with metastatic prostate adenocarcinoma
    
    ea0013p49
  - Ectopic peptide production by phaeochromocytomas
    
    ea0013p50
  - Medical treatment in adrenal insufficiency: Does the patient’s quality of life differ depending on which glucocorticoid is given?
    
    ea0013p51
  - Primary hyperparathyroidism – an unusual cause of hyperemesis gravidarum
    
    ea0013p52
  - Resistant hypercalcaemia: is it always what we think?
    
    ea0013p53
  - Safety of growth hormone replacement in patients with non-irradiated pituitary and peri-pituitary tumours
    
    ea0013p54
  - A case of giant macroprolactinoma- rapid response to dopamine agonist therapy
    
    ea0013p55
  - Iron deficiency, hypopituitarism and occram’s razor
    
    ea0013p56
  - Malignancy associated hypercalcemia with elevated levels of parathormone
    
    ea0013p57
  - Extreme pituitary hyperplasia of normal pregnancy presenting as a macroprolactinoma
    
    ea0013p58
  - How do we manage adrenal “incidentalomas” – an audit of referrals to a teaching hospital endocrine unit
    
    ea0013p59
  - Short Synacthen Test (Standard and Low dose): Do we need multiple cortisol samples?
    
    ea0013p60
  - A 57 year old lady bilateral adrenal mass and adrenal insufficiency
    
    ea0013p61
  - Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia presenting as cyclical Cushings Syndrome
    
    ea0013p62
  - Mixed TSH and GH secreting pituitary macroadenoma presenting with profound weight loss: A case report
    
    ea0013p63
  - Synacthen Tests – Do we overinvestigate?
    
    ea0013p64
  - Application of specific thyroid function test reference range in pregnancy
    
    ea0013p65
  - Has the management of treated hypothyroid mothers improved?
    
    ea0013p66
  - Fluconazole is as effective as Ketoconazole in controlling hypercortosolism
    
    ea0013p67
  - Recurrent cystic pituitary lesion - A case report
    
    ea0013p68
  - Successful management of a patient with a carcinoid tumour through 2 major operations using Octreotide – A case report
    
    ea0013p69
  - Serum prolactin normalisation does not always predict tumour shrinkage in prolactinomas: A case report.
    
    ea0013p70
  - Psychosis in a patient with acromegaly: Implications for clinical practice
    
    ea0013p71
  - A cost benefit analysis of gastric electrical stimulation (GES) in patients with severe diabetic gastoparesis
    
    ea0013p72
  - Recurrent hypoglycaemia caused by metastatic insulinoma in a patient with Type 2 diabetes
    
    ea0013p73
  - Unusual cause of adult onset hypoglycaemia post gastric bypass surgery
    
    ea0013p74
  - Hypercalcaemia associated with HTLV-1 seropositivity, but with no evidence of lymphoma
    
    ea0013p75
  - Acute falciparum malaria and parathyroid function
    
    ea0013p76
  - The role of an endocrine specialist nurse in a nurse led testosterone implant clinic
    
    ea0013p77
  - Apparent hypopituitarism secondary to Cushing’s syndrome due to adrenal carcinoma
    
    ea0013p78
  - Postmenopausal hyperandrogenism of ovarian origin: diagnostic and therapeutic difficulties
    
    ea0013p79
  - Hyperchloraemic metabolic acidosis with hypokalaemia and osteomalacia
    
    ea0013p80
  - Use of anti thyroid hormone receptor antibody (TRAB) in Graves’ Disease
    
    ea0013p81
  - Prolonged hypocalcaemia following intravenous pamidronate in hypoparathyroidism
    
    ea0013p82
  - Pituitary tumour – Contraindication to thrombolysis; Caution with antiplatelet agents
    
    ea0013p83
  - Pseudo-Bartters in diuretic and laxative abuse
    
    ea0013p84
  - Long term follow up following focused parathyroidectomy for primary hyperparathyroidism
    
    ea0013p85
  - An audit on the effectiveness of a change in RAI regime for patients with hyperthyroidism
    
    ea0013p86
  - Radioactive Iodine (I-131) and its effectiveness in treating benign thyroid disease
    
    ea0013p87
  - Hypoglycaemia secondary to leukamoid reaction
    
    ea0013p88
  - Severe hyperkalaemia and hyponatramia with grossly elevated aldosterone: pseudohypoaldosteronism
    
    ea0013p89
  - Primary hyperparathyroidism in pregnancy-an increasingly common condition?
    
    ea0013p90
  - Unusual presentation of thyroid storm
    
    ea0013p91
  - Gynecomastia caused by a urinary bladder carcinoma secreting human chorionic gonadotropin
    
    ea0013p92
  - NICE Guidelines for Adult Growth Hormone replacement: an audit of impact on practice in Scotland
    
    ea0013p93
  - Comparison of 30 minute Short Synacthen test and 60 minute Short Synacthen test for assessment of the hypothalamo-pituitary–adrenal axis
    
    ea0013p94
  - Lanreotide (Somatuline Autogel) causes marked tumour shrinkage in a case of gigantism
    
    ea0013p95
  - Cranial diabetes insipidus: An interesting case
    
    ea0013p96
  - Endocrine hypofunction as a consequence of metastatic cancer
    
    ea0013p97
  - Unusual cause of adrenal insufficiency
    
    ea0013p98
  - Use of thyroid function tests in medical inpatients in a District General Hospital
    
    ea0013p99
  - Endocrine Diagnostic Tests: A smoother, more legal diagnostic journey for the patient travelling through the Endocrine Test Care
    
    ea0013p100
  - Carney’s Triad
    
    ea0013p101
  - Gastric adenocarcinoma and ectopic ACTH syndrome
    
    ea0013p102
  - Adolescent endocrinology; time to revisit the diagnoses? a case of septo-optic dysplasia
    
    ea0013p103
  - Inherited causes and associations of medullary thyroid cancer should not be forgotten
    
    ea0013p104
  - Endocrine genes – are patients getting the optimum fit?
    
    ea0013p105
  - Adult growth hormone replacement using a fixed graded initiation phase followed by an individualised titration phase: a single centre experience
    
    ea0013p106
  - Double Y syndrome as a cause of gynaecomastia
    
    ea0013p107
  - Double Y syndrome as a cause of gynaecomastia
    
    ea0013p108
  - Does cyclical acromegaly exist?
    
    ea0013p109
  - Multicystic dysplastic kidney – a potential accelerant of complications in type I diabetes
    
    ea0013p110
  - Acute presentation of pituitary stalk tumor
    
    ea0013p111
  - Atypical presentation of isolated ACTH deficiency
    
    ea0013p112
  - Adrenal emergencies in treated addison’s disease
    
    ea0013p113
  - Inheritance in autoimmune addison’s: the extended family profile
    
    ea0013p114
- Comparative
- - Glucocorticoid metabolic pathways in human orbital adipose tissue: a comparison with subcutaneous and omental depots
    
    ea0013p115
  - Genome comparison between human chromosome 19q13 and syntenic region on mouse chromosome 7 reveals loss, in man, of 5.1 Mb containing 4 mouse G-protein coupled receptors: relevance to familial benign hypocalciuric hypercalcaemia type 3
    
    ea0013p116
  - Performance characteristics of an intact PTH recently developed for the Abbott Architect immunoassay analyser
    
    ea0013p117
- Cytokines and growth factors
- - The inter-relationship between VEGR and IGF-1 in diabetic complications
    
    ea0013p118
  - Neurotrophic factor synergy is required for neuronal survival and disinhibited axon regeneration after CNS injury
    
    ea0013p119
  - Comparative effects of vitamin D and EB1089 analoge in mRNA expression of parathyroid hormone-related peptide in prostate and breast cancer cell lines
    
    ea0013p120
  - The peripheral actions of the des-acyl and octanoylated ghrelin on leptin in human abdominal subcutaneous adipocytes
    
    ea0013p121
  - Interleukin-1alpha: the key to polycystic ovarian syndrome?
    
    ea0013p122
  - Controversial interactions between TNF-alpha and IL-6 in C2 skeletal myoblast cell death
    
    ea0013p123
  - The interleukine-6 −572G/C polymorphism is associated with type 1 diabetes mellitus in Russians and Tatars
    
    ea0013p124
- Growth and development
- - Inflammatory cytokines in juvenile idiopathic arthritis: Effects on physical growth and in vitro longitudinal bone growth
    
    ea0013p125
  - Characterisation of parathyroid-specific transcription factor Glial Cells Missing Homolog B (GCMB) in 3 families with autosomal recessive hypoparathyroidism
    
    ea0013p126
  - Neural stem cell differentiation in the injured adult mouse brain
    
    ea0013p127
  - Growth in Growth Hormone (GH) deficient dwarf rats is enhanced by variable dose GH treatment
    
    ea0013p128
  - Pituitary tumor transforming gene (PTTG), separase and Rad21 in neural cell growth
    
    ea0013p129
  - The effects of lipid-supplemented total parenteral nutrition (TPN) on hepatic and lipoprotein lipase activity in a premature neonatal piglet model
    
    ea0013p130
  - Basal gene expression patterns in children with growth hormone deficiency or Turner Syndrome
    
    ea0013p131
  - An intronic growth hormone receptor mutation causing activation of a pseudoexon is associated with a broad spectrum of growth hormone insensitivity phenotypes
    
    ea0013p132
  - The mosaic pattern of 21-OHase/LacZ transgene expression changes during organogenesis and growth of the adrenal cortex
    
    ea0013p133
  - Growth hormone replacement therapy-importance of age and sex on pre-treatment IGF-1 and responses to growth hormone therapy-reviewing age, do the 60+ require less growth hormone replacement?
    
    ea0013p134
- Diabetes, metabolism and cardiovascular
- - US Mexico border diabetes prevention and control project
    
    ea0013p135
  - Combination therapy with pioglitazone and losartan provides additional renoprotection in subjects with type 2 diabetic nephropathy
    
    ea0013p136
  - Management of gestational diabeties in a DGH setting
    
    ea0013p137
  - Dexamethasone administration does not alter serum visfatin concentrations in overweight and obese individuals
    
    ea0013p138
  - Acute glucose-induced hyperinsulinaemia during oral glucose tolerance test does not affect serum visfatin concentrations
    
    ea0013p139
  - Proactive care planning in diabetes: The benefit of enhanced primary and secondary care interaction
    
    ea0013p13^
  - cDNA expression profiling studies reveal 7 differentially expressed genes on mouse chromosome 7 that may influence renal calcification in C3H/HeH inbred mice
    
    ea0013p140
  - Expression and regulation of KiSS-1 in adipose tissue: Are kisspeptins adipokines?
    
    ea0013p141
  - Antisense oligonucleotide-induced alternative splicing of the APOB mRNA generates a novel isoform of APOB
    
    ea0013p142
  - Metabolic responses to ghrelin infusion in patients with anorexia nervosa (AN)
    
    ea0013p143
  - Skeletal muscle infarction: an uncommon complication of poorly controlled diabetes mellitus
    
    ea0013p144
  - Aldosterone-induced upregulation of urate transporter 1 may be responsible for hyperuricemia
    
    ea0013p145
  - Evaluation of impaired glucose tolerance group education sessions
    
    ea0013p146
  - Adiponectin complexes in human cerebrospinal fluid: distinct complex distribution from serum
    
    ea0013p147
  - A prospective randomised controlled trial of lifestyle intervention on quality of life and cardiovascular risk score in patients with obesity and type 2 diabetes
    
    ea0013p148
  - Metabolic cage studies reveal that mice require 5 days for acclimatisation: establishing normal urinary and blood biochemistry values in BALB/c and C3H/HeH inbred mouse strains
    
    ea0013p149
  - Bcl-2 upregulation mediates the protective effect of fluvastatin against oxidative damages in human vascular endothelial cells
    
    ea0013p150
  - Comparison of the effects of cannabinoid receptor modulation in human primary preadipocytes and a murine cell line
    
    ea0013p151
  - Effect of SOM230 on the proliferation of adult human vascular endothelial cells
    
    ea0013p152
  - Relation of amniotic fluid C-peptide and insulin level to neonatal macrosomia
    
    ea0013p153
  - Burden of Diabetes and its complications (based on recent decade studies) in Iran in year 2000
    
    ea0013p154
  - Sodium valproate monotherapy increases ovarian hyperandrogenism but does not affect arterial compliance in young women with epilepsy
    
    ea0013p155
  - Reliability on clinical features or GAD antibody measurements – which is better for diagnosis of LADA?
    
    ea0013p156
  - Prevalence of abnormal liver function tests in patients with diabetes mellitus
    
    ea0013p157
  - Modification of insulin receptor exon 11 alternative splicing by antisense oligonucleotides
    
    ea0013p158
  - The interactions between insulin and tumour necrosis factor-alpha in human aortic endothelial cells
    
    ea0013p159
  - Immunohistochemical localisation of 11β-hydroxysteroid dehydrogenase type 1 in murine pancreatic islets
    
    ea0013p160
  - HDL cholesterol levels are positively associated with testosterone and are lower with shorter androgen receptor CAG repeat lengths in men with Type 2 diabetes
    
    ea0013p161
  - The importance of gene repression for metabolic regulation in human fat
    
    ea0013p162
  - An engineered zinc finger transcription factor that activates the endogenous human insulin gene in non β cells
    
    ea0013p163
  - DHEA but not DHEAS exerts anti-glucocorticoid action in human preadipocytes
    
    ea0013p164
  - Bone marrow stem cells differentiating along the adipogenic lineage show marked up regulation of the adenosine A1 receptor transcript
    
    ea0013p165
  - The effects of glucocorticoids on the expression of gluconeogenic and lipogenic enzymes in a rodent model of Cushing’s Syndrome
    
    ea0013p166
  - 11β-Hydroxysteroid dehydrogenase-1: key regulator in oxysterol metabolism?
    
    ea0013p167
  - Usefulness of the body image assessment in obesity scale in a UK clinic population
    
    ea0013p168
  - Are there multiple endogenous glucocorticoids? Chronic Effects of 5α-Tetrahydrocorticosterone in C57BL/6 Mice
    
    ea0013p169
  - A case of renal artery stenosis presenting with polyuria and polydipsia
    
    ea0013p170
  - Abdominal obesity is associated with a decreased hepatic mRNA expression of 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) in patients with non-alcoholic steatohepatitis (NASH)
    
    ea0013p171
  - Type 2 diabetes mellitus presenting with diabetic ketoacidosis
    
    ea0013p172
  - Approaches to recapitulating development of the endocrine pancreas using mouse embryonic stem cell
    
    ea0013p173
  - Identification of orexin receptors in brown adipocytes: functional effects of orexin-B
    
    ea0013p174
  - The calcium-sensing receptor is functionally expressed in human vascular smooth muscle cells
    
    ea0013p175
  - Reduced telomere length, a marker of biological senescence, is inversely correlated with triglycerides and cholesterol in South Asian male type 2 diabetic patients
    
    ea0013p176
  - The human orexin receptor type 2 gene: Alternative promoters determining tissue-specific expression and identification of alternate splice variants and altered translational activities
    
    ea0013p177
  - Abnormalities in lipogenesis and lipolysis in Mice Lacking Hexose-6-Phosphate Dehydrogenase (H6PDH)
    
    ea0013p178
  - A characterisation of novel lipase expression and glucocorticoid regulation of lipolysis in human adipose tissue
    
    ea0013p179
  - Comparison of cardiovascular risk markers in patients with complete androgen insensitivity (CAIS) and premature ovarian failure (POF)
    
    ea0013p180
  - TRB3: A mechanism for glucocorticoid induced insulin sensitisation in human adipocytes
    
    ea0013p181
  - Insulin treatment of patients with cystic fibrosis and impaired glucose tolerance arrests the decline in pulmonary function
    
    ea0013p182
  - Depot-specific activity of NFκB and JNK in human abdominal subcutaneous and omental adipose tissue
    
    ea0013p183
  - Incidence, awareness and apparent symptoms of hypoglycaemia in patients with cystic fibrosis treated with insulin
    
    ea0013p184
  - Circulating levels of ghrelin and leptin in ANCA-associated vasculitis
    
    ea0013p185
  - Mitochondrial genes related to energy homoeostasis are dysregulated in obesity and type 2 diabetes in human adipose tissue
    
    ea0013p186
  - The prevalence and detection of vitamin d insufficiency in Asian patients with type 2 diabetes
    
    ea0013p187
  - IDF but not ATPIII predicts the presence of ischaemic heart disease
    
    ea0013p188
  - Quality of life in women attending a patient-centred, nurse-led endocrine clinic for management of polycystic ovary syndrome
    
    ea0013p189
  - Quality of life in polycystic ovary syndrome: Positive changes in women attending a patient-centred, nurse-led endocrine clinic
    
    ea0013p190
  - Renal effects of ACTH: functional and microarray studies in the mouse
    
    ea0013p191
  - Use of Octreotide in the dumping syndrome – Diabetes mellitus or disordered insulin secretion – a diagnostic dilemma?
    
    ea0013p192
  - Reduced 11beta-hydroxysteroid dehydrogenase type 1 activity in obese children
    
    ea0013p193
  - Hirsutism in PCOS – Therapeutic dilemmas…
    
    ea0013p194
  - Apoprotein B and the likelihood of myocardial infarction among persons with reduced kidney function in the U.S. population: the third national health and nutrition examination survey (NHANES III)
    
    ea0013p195
  - An assessment of some lung function parameters in Nigerian males with diabetes mellitus
    
    ea0013p196
- Endocrine tumours and neoplasia
- - Does the degree of tumour shrinkage by pre-operative treatment with lanreotide affect the surgical success in acromegaly caused by pituitary macroadenoma?
    
    ea0013p197
  - An unusual phaeochromocytoma crisis presenting with profound hypoglycaemia and subsequent hypertension
    
    ea0013p198
  - Pituitary apoplexy: an experience from a tertiary care institution in south india
    
    ea0013p199
  - Genetic background influences expression of Multiple Endocrine Neoplasia type 1 (MEN1) mutation, implicating a role for genetic modifiers
    
    ea0013p19^
  - Bone metastases in papillary carcinoma thyroid and the role of I-131 ablation
    
    ea0013p200
  - Pheochromocytoma- an experience from a south indian referral center
    
    ea0013p201
  - Impact of the implementation of European consensus guidelines on the management of differentiated Thyroid Cancer
    
    ea0013p202
  - Multiple endocrine neoplasia Type 1 (MEN1) caused by a novel mutation in intron 9 in a family with the McCune-Albright syndrome
    
    ea0013p203
  - Endogenous MC4R receptors couple to multiple MAPK pathways in hypothalamic cell lines
    
    ea0013p204
- AMEND Young Investigator's Award
- - Ghrelin, a proliferative agent in the pituitary, inhibits AMPK (AMP-dependent protein kinase), an emerging regulator of cell proliferation and metabolism
    
    ea0013p205
  - Metaiodobenzylguanidine scintigraghy (MIBG) and familial screening are not useful in phaeochromocytoma
    
    ea0013p206
  - The effect of lanreotide autogel on insulin resistance, β-cell function and related metabolic variables in acromegaly
    
    ea0013p207
  - An audit of chromogranin requests at a tertiary neuroendocrine referral centre
    
    ea0013p208
  - Insulinoma- A complicated presentation in a rare case scenario
    
    ea0013p209
  - Routine preoperative venous sampling is not necessary in aldosterone producing adenoma (Conn’s syndrome)
    
    ea0013p210
  - Successful pregnancy and delivery after total hypophysectomy
    
    ea0013p211
  - No change in brain natriuretic peptide levels after parathyroidectomy for primary hyperparathyroidism
    
    ea0013p212
  - The sodium iodide symporter (NIS) is repressed by PTTG via the human NIS upstream enhancer (hNUE)
    
    ea0013p213
  - Optimal strategy for the localisation of biochemical proven insulinomas
    
    ea0013p214
  - Post-partum hypoglycaemia; a rare presentation of insulinoma
    
    ea0013p215
  - Endoscopic pituitary surgery for acromegaly – Benefits of a specialist service
    
    ea0013p216
  - Value of early post-operative growth hormone assessment in acromegaly surgery
    
    ea0013p217
  - Steroid cell tumour of ovary presenting with virilization in patient with suspected Polycystic ovarian syndrome
    
    ea0013p218
  - Testicular teratoma, testicular seminoma and papillary thyroid carcinoma occurring in a single individual: a report of two unrelated cases
    
    ea0013p219
  - Diagnosing early acromegaly: the pre-test probability of disease is strongly influenced by the presence or absence of other associated diseases
    
    ea0013p220
  - Low penetrance of symptomatic or occult phaeochromocytoma/paraganglioma in a large kindred of subjects with a point mutation (268C>T) in exon 3 of the SDHB gene
    
    ea0013p221
  - Assessment of the efficacy and toxicity of 131I-metaiodobenzylguanidine (131I-MIBG) therapy for metastatic carcinoid tumours
    
    ea0013p222
  - Ectopic ACTH-management difficulties
    
    ea0013p223
  - Clinical impact of thyroglobulin epitope recognition pattern in patients with differentiated thyroid carcinoma and positive thyroglobulin antibodies
    
    ea0013p224
  - Evaluation of acromegaly status following surgery by OGTT, GH day curve and IGF-I: relationships between these parameters
    
    ea0013p225
- Neuroendocrinology and behaviour (including pituitary)
- - Annexin 1 interaction with calpain: a role in apoptosis
    
    ea0013p226
  - Malignant prolactinoma presenting as nasal polyp
    
    ea0013p227
  - The novel broad-spectrum somatostatin receptor agonist SOM230 (Pasireotide), blocks the adrenalectomy-induced increase in mitotic activity in male rat anterior pituitary
    
    ea0013p228
  - The effects of radiotherapy on neurocognitive function in patients treated for non-functioning pituitary adenoma
    
    ea0013p229
  - The AVP precursor, Copeptin, predicts the severity of acute and prolonged traumatic brain injury (TBI)
    
    ea0013p230
  - A prospective longitudinal study of anterior pituitary dysfunction following traumatic brain injury
    
    ea0013p231
  - Relaxin-3 stimulates the stress axis
    
    ea0013p232
  - Co-cultures of pituitary lactotrophs and folliculostellate cells stimulates connexin 43 expression: a novel role for the nucleoside adenosine
    
    ea0013p233
  - Effects of neurotensin and/or morphine on gene expression of mu and delta opioid receptor
    
    ea0013p234
  - Growth hormone sensitivity in GH deficient (GHD) hypopituitary adults is dependent on gender, but independent of timing of onset
    
    ea0013p235
  - PYY_3–36 produces an acute anorexigenic effect followed by a later orexigenic effect not seen with other anorexigenic peptides
    
    ea0013p236
  - A putative role for 11β-Hydroxysteroid dehydrogenase 1 in the regulation of cerebrospinal fluid dynamics
    
    ea0013p237
  - The effect of exogenous estradiol administration on working memory in the ovariectomised female hooded-lister rat
    
    ea0013p238
  - I am rare Turner mosaic – Can I have a baby?
    
    ea0013p239
  - Traumatic brain injury and hypopituitarism
    
    ea0013p240
  - Late development of secondary resistance to cabergoline in a patient with a lactotroph adenoma
    
    ea0013p241
  - Subclinical hypothyroidism is associated with increased cardiovascular risk: A meta-analysis
    
    ea0013p242
  - Use of the dexamethasone-suppressed corticotrophin-releasing hormone test to predict cure in patients with cushing’s disease following pituitary surgery
    
    ea0013p243
  - Non-surgical cerebro-spinal fluid rhinorrhea in invasive macroprolactinoma: incidence, radiological and clinicopathological features
    
    ea0013p244
  - Phosphorylation of MAPK family proteins by C-type natriuretic peptide (CNP) in LbetaT2 gonadotrophs – a novel cyclic GMP-independent effect?
    
    ea0013p245
  - A subnormal peak cortisol response to stimulation testing does not predict a subnormal cortisol production rate (CPR)
    
    ea0013p246
  - Sleep disorders and response to treatment in the ‘Acromegalic cardiovascular and respiratory outcomes with primary analogue therapy (ACROPAT)’ trial
    
    ea0013p247
  - RNA interference as a therapy for a model of Cushing’s disease
    
    ea0013p248
  - Sleep disorders in craniopharyngioma patients – a preliminary report
    
    ea0013p249
  - Small vessel remodelling and impaired endothelial-dependent dilatation in subcutaneous resistance arteries in patients with acromegaly
    
    ea0013p250
  - Upward resetting of osmostat – rare or under diagnosed?
    
    ea0013p251
  - AIP and familial acromegaly
    
    ea0013p252
- Reproduction
- - Successful pregnancy in a pure gonadal dysgenesis with karyotype 46, XY patient (Swyer’s syndrome)
    
    ea0013p253
  - Ghrelin is reduced in women with polycystic ovary syndrome and correlates inversely with HOMA IR and testosterone
    
    ea0013p254
  - Audit of the Polycystic Ovary Syndrome (PCOS) Nurse led weight management clinic
    
    ea0013p255
  - Differential causes of hypertriglyceridaemia and low HDL-cholesterol in women with polycystic ovary syndrome
    
    ea0013p256
  - Expression of the Anti-Mullerian hormone type II receptor (AMHRII) and related Smads in human ovarian follicles
    
    ea0013p257
  - The androgen receptor CAG repeat polymorphism is associated with serum testosterone levels and obesity in men with Type 2 diabetes
    
    ea0013p258
  - Use of long-acting intramuscular testosterone undecanoate depot (Nebido) in men with organic severe hypogonadism: initial experience from a UK tertiary referral centre
    
    ea0013p259
  - Serum anti-mullerian hormone is elevated in girls with exaggerated adrenarche
    
    ea0013p260
  - Measurement of peak and trough testosterone levels during treatment with Testogel
    
    ea0013p261
  - IGFBP-3 has both IGF-dependent and –independent effects on cytotrophoblast proliferation in the human placenta
    
    ea0013p262
  - EP²-mediated reduction of oxytocin-induced activity in term pregnant human myometrium
    
    ea0013p263
  - Retinol binding protein 4 suppresses during normal pregnancy – an inverse relationship with insulin resistance
    
    ea0013p264
  - Expression of the IGF system in the involuting bovine uterus
    
    ea0013p265
- Steroids
- - A case of Addison’s disease associated with hypogonadotrophic hypogonadism
    
    ea0013p266
  - Identification of a novel, point mutation in helix 11 of the ligand-binding domain of the human glucocorticoid receptor-α (hGRα) gene and molecular characterization of the mutant receptor hGRαF737L
    
    ea0013p267
  - A case of “cured” late-onset congenital adrenal hyperplasia
    
    ea0013p268
  - What factors influence serum testosterone levels when initiating Nebido^®?
    
    ea0013p269
  - Establishing a reference range for urine cortisol:creatinine ratio
    
    ea0013p270
  - A new source of ectopic ACTH
    
    ea0013p271
  - A central physiological role for attenuated circulating DHEAS levels in aged female Rhesus Macaques?
    
    ea0013p272
  - Aldosterone induces collagen synthesis via activation of ER1/2 in renal proximal tubular epithelial cells
    
    ea0013p273
  - A life threatening presentation of addisons disease
    
    ea0013p274
  - Genetic variation at the CYP11B locus accounts for heritabilities of aldosterone excretion and 11-beta hydroxylase activity
    
    ea0013p275
  - ACTH insensitivity syndromes; rare causes of glucocorticoid deficiency we should not forget
    
    ea0013p276
  - The effect of septic serum on adenylyl cyclase and adrenocortical responsiveness in vitro and in vivo
    
    ea0013p277
  - Testosterone and frailty in ageing men
    
    ea0013p278
  - Comparison of 24 hour urine free cortisol measurement and hydrocortisone day curve in the assessment of hydrocortisone replacement in hypoadrenal patients
    
    ea0013p279
  - Subclinical Addison’s disease
    
    ea0013p280
  - An adrenal ‘coming full circle’
    
    ea0013p281
  - Acute improvement in insulin sensitivity by PPARgamma-agonists is not mediated by inhibition of glucocorticoid action in humans
    
    ea0013p282
  - Regulation of insulin signalling across differentiation and following glucocorticoid treatment in human skeletal myocytes
    
    ea0013p283
  - Identification of novel modulators of glucocorticoid sensitivity
    
    ea0013p284
  - Does ginseng ingestion influence salivary testosterone and DHEA levels in females
    
    ea0013p285
  - Effect of Glycaemic index of the diet on salivary cortisol and testosterone levels in females
    
    ea0013p286
  - Unusually mild phenotypic presentation in a family with CYP17A1 deficiency detected by urinary steroid profiling
    
    ea0013p287
  - Glucose-6-phosphate disposal and regulation of 11β-hydroxysteroid Dehydrogenase type 1: A new link between cellular glucose metabolism and the HPA axis
    
    ea0013p288
  - Is the rate of fall in total testosterone steeper among men in the eighth decade of life?
    
    ea0013p289
  - Glucocorticoid treatment and the consequences in adults with congenital adrenal hyperplasia
    
    ea0013p290
  - The effects of glucocorticoids on the expression of gluconeogenic and lipogenic enzymes in a rodent model of Cushing’s Syndrome
    
    ea0013p291
- Thyroid
- - The calcium-sensing receptor is a target of autoantibodies in patients with autoimmune polyendocrine syndrome type 1
    
    ea0013p292
  - Persistent hypothyroidism despite optimal therapy: time to rethink
    
    ea0013p293
  - Thyroid storm precipitated by trauma: a rare presentation with right heart failure and liver dysfunction
    
    ea0013p294
  - An audit of radioiodine treatment for thyrotoxicosis in a large district hospital
    
    ea0013p295
  - Removal of tick box for TFT in pathology request forms reduces TFT performed during acute medical admission
    
    ea0013p296
  - Pendred syndrome;a comparison between new and old diagnostic approaches
    
    ea0013p297
  - Assessment and management of non-compliant hypothyroid patients: the role of weekly observed thyroxine therapy
    
    ea0013p298
  - T3:TRAB ratio predicts patients with Graves’ thyrotoxicosis who cannot be controlled with antithyroid drug therapy and relapse at 2 years
    
    ea0013p299
  - Chronic leg rash in Graves disease, not always pretibial myxedema
    
    ea0013p300
  - The scope of cardiac complications of thyrotoxicosis in Lagos, Nigeria
    
    ea0013p301
  - The outcome of the management of subclinical hyperthyroidism: Use of fixed dose of radioiodine therapy
    
    ea0013p302
  - W546X mutation of the thyrotropin receptor, cause of subclinical hypothyroidism (SH) in various clinical settings
    
    ea0013p303
  - Can neonatal TSH screening detect trends in population iodine intake?
    
    ea0013p304
  - Seaweed as a model for iodide accumulation and storage
    
    ea0013p305
  - Outcome of radio-active iodine treatment for thyrotoxicosis in Glan Clwyd Hospital 2003–2005
    
    ea0013p306
  - Can parathyroid hormone (PTH) levels be useful in predicting postoperative hypocalcaemia in patients undergoing total thyroidectomy?
    
    ea0013p307
  - Stridor as the initial presentation of large retrosternal goitre
    
    ea0013p308
  - An audit of radio active iodine treatment in the management of thyrotoxicosis at a district general hospital
    
    ea0013p309
  - Retrospective analysis of radioactive iodine (I¹³¹) treatment for hyperthyroidism
    
    ea0013p310
  - A case of Burkitt’s lymphoma of the thyroid presenting as myxoedema coma
    
    ea0013p311
  - Using an increased fixed dose of ¹³¹I (600MBq) leads to improved outcome in patients with hyperthyroidism
    
    ea0013p312
  - Effects of neurotensin and/or morphine on gene expression of mu and delta opioid receptor
    
    ea0013p313
  - Only one in four patients with suspicious thyroid cytology (THY3) has a thyroid carcinoma
    
    ea0013p314
  - Subclinical hyperthyroidism in cats
    
    ea0013p315
  - Does synthetic thyroid extract work for everybody?
    
    ea0013p316
  - Routine screening for thyroid disease in patients with diabetes mellitus: is it worthwhile?
    
    ea0013p317
  - Assessment of catecholamines in patients with simple nodular goiter
    
    ea0013p318
  - Retrospective analysis of radioiodine therapy for thyrotoxicosis with a 550Mbq dose
    
    ea0013p319
  - Thyroid function testing in hypothyroid women during pregnancy
    
    ea0013p320
  - Central arterial stiffness in resistance to thyroid hormone
    
    ea0013p321
  - Audit of follow-up after radio-iodine treatment for hyperthyroidism in East and North Hertfordshire NHS Trust
    
    ea0013p322
  - The unrecognised use of alternative treatments for thyroid disorders
    
    ea0013p323
  - Management of thyroid nodules – Local experience at a district general hospital in UK
    
    ea0013p324
  - Preliminary evidence for association of PTPN12 with Graves’ ophthalmopathy
    
    ea0013p325
  - Thyrotoxicosis complicating a molar pregnancy
    
    ea0013p326
  - RET proto-oncogene exon 11 germline mutations in patients with medullary thyroid carcinoma
    
    ea0013p327
  - T3 rather than TSH mediates the effects of altered thyroid status on bone turnover in man
    
    ea0013p328
  - Thyroid eye disease: adjusting to an altered sense of identity influences patients’ interactions with healthcare professionals
    
    ea0013p329
  - Plasminogen activators in human thyroid follicular cells
    
    ea0013p330
  - Hypoxia inducible factor (HIF-1α) in thyroid carcinoma cell lines
    
    ea0013p331
  - Propylthiouracil induced foetal goitre: a food for thought
    
    ea0013p332
  - Neuropsychological abnormalities in overt and sub-clinical hypothyroidism improve but do not normalise following 3 months replacement with L-thyroxine
    
    ea0013p333
  - Severe thyroid orbitopathy and ocular myasthenia gravis. A challenging case, and review of the literature
    
    ea0013p334
  - Effect of methimazole on the immunoreactivity of recombinant thyroid peroxidase
    
    ea0013p335
  - Role of Liothyronine in thyroid replacement therapy – a retrospective audit
    
    ea0013p336
  - Should long-term continuous anti-thyroid drug therapy be included in the therapeutic armamentarium for hyperthyroidism?
    
    ea0013p337
  - The relative level and predictors of osteoporotic fracture in patients with treated thyroid dysfunction
    
    ea0013p338
  - Weekly thyroxine administration: a safe method to administer thyroxine when compliance issues arise
    
    ea0013p339
  - Pyogenic thyroiditis with hyperthyroxinaemia
    
    ea0013p340
  - The relationship between serum TSH levels and blood pressure in a population sample with normal thyroid function
    
    ea0013p341
  - Hyperemesis gravidarum and gestational hyperthyroidism
    
    ea0013p342
- Novartis Prize posters
- - Steroidogenic gene transcription in the human hippocampus and cerebellum: a comprehensive survey
    
    ea0013np1
  - Kisspeptin-54 potently stimulates luteinising hormone release during the preovulatory phase of the menstrual cycle in healthy human females
    
    ea0013np2

Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 | Privacy policy | Cookie settings

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more

Endocrine Abstracts

Society for Endocrinology BES

Contents

BiosciAbstracts